Surgical and interventional palliative treatment of upper gastrointestinal malignancies

David Rice, Alex Geller, Claire E. Bender, Christopher J. Gostout, John H. Donohue

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


Malignancies of the upper gastrointestinal tract, including the oesophagus, stomach, liver, bile ducts and pancreas, are highly virulent diseases. While curative therapies relieve symptoms caused by these cancers, most of these treatments prove unsuccessful in the control of tumour due to occult residual disease. This review covers only planned palliative procedures for these conditions where patient factors (e.g. performance status or patient wishes) or tumour factors (e.g. locally advanced or known metastatic disease) prevent potentially curative intervention. For most patients, palliation of luminal obstruction, pain or other symptoms is the most worthwhile treatment that can be offered with present therapies. (C) 2000 Lippincott Williams and Wilkins.

Original languageEnglish (US)
Pages (from-to)403-408
Number of pages6
JournalEuropean Journal of Gastroenterology and Hepatology
Issue number4
StatePublished - 2000


  • Bypass
  • Carcinoma of oesophagus
  • Carcinoma of pancreas
  • Carcinoma of stomach
  • Cholangiocarcinoma
  • Hepatocellular carcinoma
  • Palliative management
  • Surgery

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology


Dive into the research topics of 'Surgical and interventional palliative treatment of upper gastrointestinal malignancies'. Together they form a unique fingerprint.

Cite this